Skip to Content

Fluarix Approval History

  • FDA approved: Yes (First approved August 31st, 2005)
  • Brand name: Fluarix
  • Generic name: influenza virus vaccine, inactivated
  • Company: GlaxoSmithKline
  • Treatment for: Influenza Prophylaxis

Fluarix (influenza virus vaccine, inactivated) is an influenza virus vaccine indicated for the prevention of influenza.

Development History and FDA Approval Process for Fluarix

Jan 11, 2018Approval GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
Dec 17, 2012Approval FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
Oct 19, 2009Approval FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
Aug 31, 2005Approval Fluarix GlaxoSmithKline - Treatment for Influenza Vaccination
May 25, 2005GlaxoSmithKline Submits Biologics License Application for FDA Approval of Fluarix

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.